[go: up one dir, main page]

AUPR320701A0 - The new cancer therapeutic agent with a thiopeptides - Google Patents

The new cancer therapeutic agent with a thiopeptides

Info

Publication number
AUPR320701A0
AUPR320701A0 AUPR3207A AUPR320701A AUPR320701A0 AU PR320701 A0 AUPR320701 A0 AU PR320701A0 AU PR3207 A AUPR3207 A AU PR3207A AU PR320701 A AUPR320701 A AU PR320701A AU PR320701 A0 AUPR320701 A0 AU PR320701A0
Authority
AU
Australia
Prior art keywords
thiopeptides
therapeutic agent
cancer therapeutic
new cancer
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR3207A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AUPR3207A priority Critical patent/AUPR320701A0/en
Publication of AUPR320701A0 publication Critical patent/AUPR320701A0/en
Priority to PCT/KR2002/000256 priority patent/WO2002066046A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AUPR3207A 2001-02-20 2001-02-20 The new cancer therapeutic agent with a thiopeptides Abandoned AUPR320701A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AUPR3207A AUPR320701A0 (en) 2001-02-20 2001-02-20 The new cancer therapeutic agent with a thiopeptides
PCT/KR2002/000256 WO2002066046A1 (fr) 2001-02-20 2002-02-19 Agent anticancereux contenant un thiopeptide a multiples noyaux thiazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR3207A AUPR320701A0 (en) 2001-02-20 2001-02-20 The new cancer therapeutic agent with a thiopeptides

Publications (1)

Publication Number Publication Date
AUPR320701A0 true AUPR320701A0 (en) 2001-03-15

Family

ID=3827226

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR3207A Abandoned AUPR320701A0 (en) 2001-02-20 2001-02-20 The new cancer therapeutic agent with a thiopeptides

Country Status (2)

Country Link
AU (1) AUPR320701A0 (fr)
WO (1) WO2002066046A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004074295A1 (fr) * 2003-02-21 2004-09-02 Keio University Polymeres cycliques de thiazole, leur procede de preparation, leurs intermediaires de synthese et leur utilisation
WO2005115374A1 (fr) * 2004-05-29 2005-12-08 7Tm Pharma A/S Ligands du recepteur crth2 utilises a des fins therapeutiques
MX2008013381A (es) * 2006-04-18 2009-01-19 Piramal Life Sciences Ltd Nuevos compuestos antibacterianos.
JP2013503624A (ja) * 2009-09-02 2013-02-04 ピラマル・ライフ・サイエンシーズ・リミテッド 抗生物質化合物
WO2012062906A1 (fr) 2010-11-11 2012-05-18 Instituto Biomar, S.A. Peptides en tant que composés bioactifs
TWI830837B (zh) 2018-12-17 2024-02-01 西班牙商瑪製藥股份有限公司 抗腫瘤化合物
WO2020142782A1 (fr) * 2019-01-04 2020-07-09 University Of Vermont And State Agricultural College Compositions et procédés thérapeutiques contre le cancer et de vitamine e
CN113769064A (zh) * 2021-09-28 2021-12-10 上海交通大学医学院附属第九人民医院 硫链丝菌素在制备牙周炎治疗药物中的应用
CN113769060A (zh) * 2021-09-28 2021-12-10 上海交通大学医学院附属第九人民医院 那西肽在制备牙周炎治疗药物中的应用
WO2024136758A1 (fr) * 2022-12-21 2024-06-27 Agency For Science, Technology And Research Composés de thiopeptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5663918A (en) * 1979-10-30 1981-05-30 Shionogi & Co Ltd Antitumorigenic agent containing siomycin half ester
KR100313402B1 (ko) * 1998-10-08 2002-02-19 장인순 치오아세틸디펩티드유도체와이로부터제조되는이기능성리간드및그제조방법

Also Published As

Publication number Publication date
WO2002066046A1 (fr) 2002-08-29

Similar Documents

Publication Publication Date Title
AUPS054702A0 (en) Cancer therapy
AU2002365120A1 (en) Medicaments
AU2002258063A1 (en) Medicament applicator
AU2002253490A1 (en) A catheter
AU2002356967A1 (en) Catheter
AU2002359163A1 (en) New use
AU2002253039A1 (en) Tramadol-based medicament
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AUPR320701A0 (en) The new cancer therapeutic agent with a thiopeptides
AU2001243515A1 (en) Combination drug therapy
AU2002353739A1 (en) Therapeutic compounds
AU2002216758A1 (en) Quinazolines with therapeutic use
AU2002335667A1 (en) Modified reoviral therapy
AU2001275696A1 (en) Therapeutic agent
AU2002351382A1 (en) Combination cancer therapy
AU2001292897A1 (en) Novel therapy
AU2002332636A1 (en) Wild-type ras as a cancer therapeutic agent
AU2002339178A1 (en) Quinazoline compounds with therapeutic use
AUPR743101A0 (en) A cancer therapeutic
AU2002310189A1 (en) Tumor therapy
AUPR969801A0 (en) Therapeutic compounds - ii
AUPR238701A0 (en) Therapy regimen
AU2002236072A1 (en) Medicaments
AU2002234987A1 (en) Cancer therapeutic agent comprising thiopeptide with multiple thiazole rings
HK1067537A (en) Wild-type ras as a cancer therapeutic agent